z-logo
open-access-imgOpen Access
Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes” (J Clin Endo Metab Case Reports. 2023; 1(1): 10.1210/jcemcr/luac017)
Publication year - 2022
Publication title -
jcem case reports
Language(s) - English
Resource type - Journals
ISSN - 2755-1520
DOI - 10.1210/jcemcr/luad005
Subject(s) - semaglutide , agonist , endocrinology , type 2 diabetes , medicine , type (biology) , exenatide , receptor , chemistry , diabetes mellitus , biology , liraglutide , ecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom